Zucomet VG 1mg/500mg/0.2mg Tablet
Marketer
Zuciya Lifesciences
Salt Composition
Glimepiride (1mg) + Metformin (500mg) + Voglibose (0.2mg)
Overview Zucomet VG 1mg/500mg/0.2mg Tablet
Diabexe Trio 1mg/500mg/0.2mg tablets are classified as antidiabetic medications. This combination therapy is indicated for adult patients with type 2 diabetes mellitus to manage blood glucose control. Diabexe Trio should be administered with food, consistently at the same time daily for optimal effectiveness. Dosage is determined and adjusted by your physician based on your blood sugar response. Continuous use is crucial, even with well-controlled blood sugar, as abrupt cessation can elevate glucose levels, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. Remember, this medication is one component of a comprehensive treatment plan encompassing diet modification, regular exercise, and weight management as directed by your doctor. Lifestyle choices significantly impact diabetes management. Hypoglycemia (low blood sugar) is a prevalent side effect, characterized by symptoms such as sweating, lightheadedness, headache, and tremors. Learn to recognize and manage these symptoms; maintain regular meals and always carry a rapid-acting glucose source like sugary snacks or juice. Alcohol consumption elevates hypoglycemia risk and should be avoided. Additional potential side effects include altered taste perception, nausea, diarrhea, abdominal discomfort, headache, edema, visual disturbances, bone fractures, and upper respiratory infections. Weight gain is also possible. This medication is contraindicated in patients with type 1 diabetes mellitus, diabetic ketoacidosis, or severe hepatic or renal impairment. Prior heart disease should be disclosed to your physician before commencing treatment. Pregnant or lactating women must consult their doctor before use. Regular blood glucose monitoring is essential, and your doctor might recommend blood tests to assess blood cell counts and liver function.
Primary Ingredients of Zucomet VG 1mg/500mg/0.2mg Tablet
The provided text is "undefined," therefore no rephrasing is possible.
Uses of Zucomet VG 1mg/500mg/0.2mg Tablet
Managing Type 2 Diabetes
Major Benefits of Zucomet VG 1mg/500mg/0.2mg Tablet:
Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Consume the Zucomet VG 1mg/500mg/0.2mg Tablet on an empty stomach.
Common Side effects of Zucomet VG 1mg/500mg/0.2mg Tablet:
- Nausea
- Diarrhea
- Abdominal pain
- Hypoglycemia (low blood glucose level)
- Loss of appetite
How to use Zucomet VG 1mg/500mg/0.2mg Tablet:
Consume this medication precisely as your physician directs, adhering to the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Take Zucomet VG 1mg/500mg/0.2mg Tablet on an empty stomach.
How Zucomet VG 1mg/500mg/0.2mg Tablet works:
Each Zucomet VG tablet (1mg/500mg/0.2mg) combines three distinct antidiabetic agents.
SAFETY ADVICE
AlcoholUNSAFE
Combining Zucomet VG 1mg/500mg/0.2mg tablets with alcohol is not advisable.
PregnancyCONSULT YOUR DOCTOR
The use of Zucomet VG 1mg/500mg/0.2mg Tablet during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the potential advantages against any risks prior to prescribing this medication. Physician consultation is recommended.
Breast feedingCONSULT YOUR DOCTOR
The use of Zucomet VG 1mg/500mg/0.2mg tablets while breastfeeding is likely inadvisable. Preliminary evidence in humans indicates potential transfer to breast milk with the possibility of infant harm.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar imbalances.
KidneyUNSAFE
Patients with kidney disease should likely avoid Zucomet VG 1mg/500mg/0.2mg Tablets, as their use may be unsafe. Medical advice is recommended. The use of Zucomet VG 1mg/500mg/0.2mg Tablets is contraindicated in patients experiencing severe kidney impairment.
LiverCAUTION
Patients with liver impairment should use Zucomet VG 1mg/500mg/0.2mg tablets cautiously, potentially requiring dosage modification. Consult a physician. In individuals with mild to moderate liver disease, initiation should be at a low dosage; the medication is contraindicated for those with severe hepatic dysfunction.
What if you forget to take Zucomet VG 1mg/500mg/0.2mg Tablet :
Should you forget a Zucomet VG 1mg/500mg/0.2mg Tablet dose, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Zucomet VG 1mg/500mg/0.2mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
3,018 People bought this recently